VIAL HEALTH TECHNOLOGY, INC.

Lobbying for VIAL HEALTH TECHNOLOGY, INC. · Vial is a clinical stage biopharmaceutical company.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$280,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 9

Defense, Dept of (DOD)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE
Vice President of the U.S.
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Regulatory and policy issues related to drug development and clinical trials

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.